Randomized Placebo-controlled Trial Of An Isoflavone Supplement And Menopausal Symptoms In Women
| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 43 |
| Gender | Female |
| Age Range | 45-64 |
| Body Types | Overweight |
Supplementation of 40mg Promensil daily over the course of three months was noted to reduce hot flashes relative to placebo when measured at four weeks, but over the course of the 12 week study there were no significant differences in overall menopausal symptoms (Greene Climacteric Scale) or hot flash occurrence.Funding issues for this study:
Study was Financially Supported by producers of the supplement; Novagen
